Your search for Regulatory Science Symposium: Diversity in Clinical Trials in the Time of COVID-19 in Online Educational Library returned the following results. Back to all results.

Online Educational Library

Regulatory Science Symposium: Diversity in Clinical Trials in the Time of COVID-19 Session 1: Introduction

regulatory science , clinical trials , quality science , diversity

Regulatory Science Symposium: Diversity in Clinical Trials in the Time of COVID-19 Session 5: Diversity, Equity and Inclusion in Clinical Research

clinical research , diversity , inclusion , patient-focused care , patient voice , patient recruitment

Regulatory Science Symposium: Diversity in Clinical Trials in the Time of COVID-19 Session 3: FDA Initiatives to Address Diversity in Clinical Trials

clinical trials , academia , clinical research , diversity , inclusion , fda , guidances , regulations , nih , barriers to patient access

Regulatory Science Symposium: Diversity in Clinical Trials in the Time of COVID-19 Session 6: Populations on the Fringe of Clinical Trial Enrollment

study design , clinical trials , diversity , inclusion , barriers to patient access , disparities in research , vulnerable populations , representation , subject eligibility criteria

Regulatory Science Symposium: Diversity in Clinical Trials in the Time of COVID-19 Session 2: What Do We Mean by Diversity in Clinical Trials?

regulatory science , study design , clinical trials , diversity , study populations , inclusion

Regulatory Science Symposium: Diversity in Clinical Trials in the Time of COVID-19 Session 7: Ensuring Participant Diversity and Engagement During COVID-19

study design , diversity , inclusion , barriers to patient access , disparities in research , clinical trial recruitment , inequity

Regulatory Science Symposium: Diversity in Clinical Trials in the Time of COVID-19 Session 8: Wrap-Up

regulatory science , quality science , surveys , research

Regulatory Science Symposium: Diversity in Clinical Trials in the Time of COVID-19 Session 4: Clinical Trials Participation: Understanding the Needs and Importance of Diverse Populations

technology , clinical research , inclusion , barriers to patient access , surveys , patient-reported outcomes , patient-focused care , dissemination of information , marketing strategies

NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.